Analyze Diet
Journal of cellular physiology2011; 227(3); 1250-1256; doi: 10.1002/jcp.22953

Blood derived stem cells: an ameliorative therapy in veterinary ophthalmology.

Abstract: Stem cell technology has evoked considerable excitement among people interested in the welfare of animals, as it has suggested the potential availability of new tools for several pathologies, including eye disease, which in many cases is considered incurable. One such example is ulcerative keratitis, which is very frequent in horses. Because some of these corneal ulcers can be very severe, progress rapidly and, therefore, can be a possible cause of vision loss, it is important to diagnose them at an early stage and administer an appropriate treatment, which can be medical, surgical, or a combination of both. The therapeutic strategy should eradicate the infection in order to reduce or stop destruction of the cornea. In addition, it should support the corneal structures and control the uveal reaction, and the pain associated with it, in order to minimize scarring. In this study, we address how stem cells derived from peripheral blood can be used also in ophthalmological pathologies. Our results demonstrate that this treatment protocol improved eye disease in four horse cases, including corneal ulcers and one case of retinal detachment. In all cases, we detected a decrease in the intense inflammatory reaction as well as the restoration of the epithelial surface of the central cornea.
Publication Date: 2011-07-28 PubMed ID: 21792938DOI: 10.1002/jcp.22953Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Case Reports
  • Journal Article
  • Research Support
  • Non-U.S. Gov't

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

This research investigates the use of peripheral blood-derived stem cells in treating certain eye diseases, like ulcerative keratitis and retinal detachment, in horses. The study found a decrease in inflammation and recovery of the central cornea’s epithelial surface after treatment.

Objective of the Study

  • The research aims to explore the use of stem cells derived from peripheral blood as a treatment for ophthalmological pathologies, particularly ulcerative keratitis, a common eye disease in horses that often leads to vision loss, and retinal detachment.

Background and Implications

  • Stem cell technology has been seen as a potential solution to several diseases, including those previously thought to be incurable. This study targets the common and often severe equine eye disease of ulcerative keratitis and the relatively rarer case of retinal detachment, suggesting a new possible treatment protocol.
  • Effective and early management of these eye diseases is critical both in preventing damage to the cornea that might lead to vision loss and also in controlling associated infections and pain.

Methodology & Results

  • The researchers used stem cells derived from peripheral blood to treat the equine subjects suffering from corneal ulcers and retinal detachment. Following the treatment protocol, the results showed signs of improvement in eye conditions.
  • In all cases, the researchers observed a reduction in the intense inflammatory reaction, which is typically a response to such eye diseases. Additionally, they witnessed the restoration of the epithelial surface of the central cornea, indicating successful repair and hence successful treatment.

Conclusions & Future Research

  • The study concludes that the use of peripheral blood-derived stem cells can be an effective alternative treatment for certain ophthalmological diseases in horses. However, further research with a larger sample size and variety of conditions might be needed to fully establish the potential of this treatment.
  • The findings have significant implications for veterinary care, heralding the possibility of better management and treatment of equine eye diseases. Furthermore, it could open avenues to investigate the effectiveness of stem cell technology in treating other diseases in diverse veterinary applications.

Cite This Article

APA
Marfe G, Massaro-Giordano M, Ranalli M, Cozzoli E, Di Stefano C, Malafoglia V, Polettini M, Gambacurta A. (2011). Blood derived stem cells: an ameliorative therapy in veterinary ophthalmology. J Cell Physiol, 227(3), 1250-1256. https://doi.org/10.1002/jcp.22953

Publication

ISSN: 1097-4652
NlmUniqueID: 0050222
Country: United States
Language: English
Volume: 227
Issue: 3
Pages: 1250-1256

Researcher Affiliations

Marfe, Gabriella
  • Department of Experimental Medicine and Biochemical Sciences, University of Rome Tor Vergata, Rome, Italy. gabriellamarfe@libero.it
Massaro-Giordano, Mina
    Ranalli, Marco
      Cozzoli, Eliana
        Di Stefano, Carla
          Malafoglia, Valentina
            Polettini, Marco
              Gambacurta, Alessandra

                MeSH Terms

                • Animals
                • Bites and Stings / pathology
                • Bites and Stings / therapy
                • Bites and Stings / veterinary
                • Corneal Ulcer / pathology
                • Corneal Ulcer / therapy
                • Corneal Ulcer / veterinary
                • Eye Diseases / pathology
                • Eye Diseases / therapy
                • Eye Diseases / veterinary
                • Female
                • Hematopoietic Stem Cell Transplantation / methods
                • Hematopoietic Stem Cell Transplantation / veterinary
                • Horse Diseases / pathology
                • Horse Diseases / therapy
                • Horses
                • Keratitis / pathology
                • Keratitis / therapy
                • Keratitis / veterinary
                • Male
                • Retinal Detachment / pathology
                • Retinal Detachment / therapy
                • Retinal Detachment / veterinary
                • Uveitis / parasitology
                • Uveitis / therapy
                • Uveitis / veterinary

                Citations

                This article has been cited 13 times.
                1. Young KAS, Schnabel LV, Gilger BC. Cell and Gene Therapy in Equine Ocular Disease. Vet Ophthalmol 2026 Mar;29(2):e70151.
                  doi: 10.1111/vop.70151pubmed: 41623202google scholar: lookup
                2. Sharun K, Banu SA, Alifsha B, Abualigah L, Pawde AM, Dhama K, Pal A. Mesenchymal stem cell therapy in veterinary ophthalmology: clinical evidence and prospects. Vet Res Commun 2024 Dec;48(6):3517-3531.
                  doi: 10.1007/s11259-024-10522-wpubmed: 39212813google scholar: lookup
                3. El-Husseiny HM, Mady EA, Helal MAY, Tanaka R. The Pivotal Role of Stem Cells in Veterinary Regenerative Medicine and Tissue Engineering. Vet Sci 2022 Nov 21;9(11).
                  doi: 10.3390/vetsci9110648pubmed: 36423096google scholar: lookup
                4. Cequier A, Sanz C, Rodellar C, Barrachina L. The Usefulness of Mesenchymal Stem Cells beyond the Musculoskeletal System in Horses. Animals (Basel) 2021 Mar 25;11(4).
                  doi: 10.3390/ani11040931pubmed: 33805967google scholar: lookup
                5. Voga M, Adamic N, Vengust M, Majdic G. Stem Cells in Veterinary Medicine-Current State and Treatment Options. Front Vet Sci 2020;7:278.
                  doi: 10.3389/fvets.2020.00278pubmed: 32656249google scholar: lookup
                6. MacDonald ES, Barrett JG. The Potential of Mesenchymal Stem Cells to Treat Systemic Inflammation in Horses. Front Vet Sci 2019;6:507.
                  doi: 10.3389/fvets.2019.00507pubmed: 32039250google scholar: lookup
                7. Gambacurta A, Merlini G, Ruggiero C, Diedenhofen G, Battista N, Bari M, Balsamo M, Piccirillo S, Valentini G, Mascetti G, Maccarrone M. Human osteogenic differentiation in Space: proteomic and epigenetic clues to better understand osteoporosis. Sci Rep 2019 Jun 6;9(1):8343.
                  doi: 10.1038/s41598-019-44593-6pubmed: 31171801google scholar: lookup
                8. Arianna C, Eliana C, Flavio A, Marco R, Giacomo D, Manuel S, Elena B, Alessandra G. Rapid Rapamycin-Only Induced Osteogenic Differentiation of Blood-Derived Stem Cells and Their Adhesion to Natural and Artificial Scaffolds. Stem Cells Int 2017;2017:2976541.
                  doi: 10.1155/2017/2976541pubmed: 28814956google scholar: lookup
                9. Sherman AB, Gilger BC, Berglund AK, Schnabel LV. Effect of bone marrow-derived mesenchymal stem cells and stem cell supernatant on equine corneal wound healing in vitro. Stem Cell Res Ther 2017 May 25;8(1):120.
                  doi: 10.1186/s13287-017-0577-3pubmed: 28545510google scholar: lookup
                10. Zahedi M, Parham A, Dehghani H, Mehrjerdi HK. Stemness Signature of Equine Marrow-derived Mesenchymal Stem Cells. Int J Stem Cells 2017 May 30;10(1):93-102.
                  doi: 10.15283/ijsc16036pubmed: 28222255google scholar: lookup
                11. Carpentieri A, Cozzoli E, Scimeca M, Bonanno E, Sardanelli AM, Gambacurta A. Differentiation of human neuroblastoma cells toward the osteogenic lineage by mTOR inhibitor. Cell Death Dis 2015 Nov 12;6(11):e1974.
                  doi: 10.1038/cddis.2015.244pubmed: 26561783google scholar: lookup
                12. Spaas JH, Broeckx S, Van de Walle GR, Polettini M. The effects of equine peripheral blood stem cells on cutaneous wound healing: a clinical evaluation in four horses. Clin Exp Dermatol 2013 Apr;38(3):280-4.
                  doi: 10.1111/ced.12068pubmed: 23517358google scholar: lookup
                13. Zhang Y, Huang B. Peripheral blood stem cells: phenotypic diversity and potential clinical applications. Stem Cell Rev Rep 2012 Sep;8(3):917-25.
                  doi: 10.1007/s12015-012-9361-zpubmed: 22451417google scholar: lookup